Brief: Roivant Reports Positive Initial Phase 2 Results For Batoclimab In Graves’ Disease

Immunovant

20/12/2023 23:14

Dec 20 (Reuters) - Immunovant Inc  IMVT.O :
    * ROIVANT REPORTS POSITIVE INITIAL PHASE 2 RESULTS FOR
BATOCLIMAB
IN GRAVES’ DISEASE
    * ROIVANT SCIENCES LTD - INTEND TO FOCUS OUR FUTURE
DEVELOPMENT IN
GRAVES' ON IMVT-1402, WITH PLANS EXPECTED TO BE ANNOUNCED LATER
IN 2024
    * ROIVANT SCIENCES LTD - BATOCLIMAB WAS GENERALLY WELL
TOLERATED
WITH NO NEW SAFETY SIGNALS OBSERVED IN INITIAL DATA SET

Source text for Eikon:  ID:nGNX61ZPDs 
Further company coverage:  IMVT.O 

 ((Reuters.Briefs@thomsonreuters.com;))